OC&C advises PSG and Rivean on acquisition of French healthcare-tech provider Sofia Développement

We are pleased to congratulate PSG Equity and Rivean Capital on their acquisition of Sofia Développement, and to have supported them with commercial due diligence for this transaction.

Sofia Développement is a leading provider of practice management software to outpatient healthcare professionals in France. Currently servicing over 38,000 users across health care services, including nurses, physiotherapists, and more. Now, Sofia Développement will join forces with Corilus, a multi-speciality healthcare software business backed by PSG and Rivean, with a strong presence in Belgium and a user base of 40,000 professionals.

This combination creates an international healthcare software platform, supporting more than 70,000 outpatient care professionals. It will operate at a significantly greater scale and serve a wider geographic footprint, allowing it to offer enhanced support to outpatient professionals across a broad range of specialisms. The group will also be well placed to accelerate innovation in the sector, including the development of AI-driven tools, improved patient engagement systems and more integrated care solutions.

We wish PSG, Rivean, Corilus and Sofia Développement every success in this next phase of growth.

OC&C and Private Equity

We’re a leading global strategy consultancy, with deep expertise in Software & Technology sector, and within that a thriving Healthcare software & Tech practice. We work with both major global corporations and local champions. In private equity, we have commercially advised on more than 500 successful transactions over the last 5 years, encompassing sell-side and buy-side roles.

How we can help:

• We provide commercial due diligence and vendor due diligence for transactions.
• We assist investors with accelerating or improving their portfolio companies’ performance.
• We help investors identify potential investment themes or assets to target.
• We can translate your investment thesis into an actionable 3–5 year value creation plan.

For more details on our experience in this space, get in touch with our experts below or email [email protected]